Xavier Michelet

Company: MiNK Therapeutics

Job title: Associate director

Seminars:

Panel Discussion: The Trials & Tribulations of Bispecifics 2:00 pm

Looking back at the problems bispecific antibody programs have faced with Examine the strengths what strengths bispecifics are still known to have Suggest what could be done in the early research and translational stages to mitigate these challenges, as well as whether sufficient tools exist to predict potential issuesRead more

day: Day Two